Qian JY - Search Results

1

Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression.

Zhu L, Li XX, Shi L, Wu J, Qian JY, Xia TS, Zhou WB, Sun X, Zhou XJ, Wei JF, Ding Q. Zhu L, et al. Among authors: qian jy. Oncol Rep. 2019 Jan;41(1):455-464. doi: 10.3892/or.2018.6842. Epub 2018 Nov 1. Oncol Rep. 2019. PMID: 30542717

2

Identifying the role of Wilms tumor 1 associated protein in cancer prediction using integrative genomic analyses.

Wu LS, Qian JY, Wang M, Yang H. Wu LS, et al. Among authors: qian jy. Mol Med Rep. 2016 Sep;14(3):2823-31. doi: 10.3892/mmr.2016.5528. Epub 2016 Jul 18. Mol Med Rep. 2016. PMID: 27430156

3

Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells.

He J, Ma G, Qian J, Zhu Y, Liang M, Yao N, Ding Q, Chen L, Liu X, Xia T, Wang S. He J, et al. Med Sci Monit. 2017 Apr 1;23:1583-1596. doi: 10.12659/msm.904124. Med Sci Monit. 2017. PMID: 28364518 Free PMC article.

4

PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.

Zhou XJ, Wu J, Shi L, Li XX, Zhu L, Sun X, Qian JY, Wang Y, Wei JF, Ding Q. Zhou XJ, et al. Among authors: qian jy. J Exp Clin Cancer Res. 2017 Oct 19;36(1):149. doi: 10.1186/s13046-017-0620-3. J Exp Clin Cancer Res. 2017. PMID: 29052531 Free PMC article.

5

KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.

Qian JY, Gao J, Sun X, Cao MD, Shi L, Xia TS, Zhou WB, Wang S, Ding Q, Wei JF. Qian JY, et al. Oncogene. 2019 Aug;38(33):6123-6141. doi: 10.1038/s41388-019-0861-z. Epub 2019 Jul 8. Oncogene. 2019. PMID: 31285549

6

SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer.

Zhang X, Dai XY, Qian JY, Xu F, Wang ZW, Xia T, Zhou XJ, Li XX, Shi L, Wei JF, Ding Q. Zhang X, et al. Among authors: qian jy. Mol Ther Nucleic Acids. 2021 Aug 19;27:133-146. doi: 10.1016/j.omtn.2021.08.009. eCollection 2022 Mar 8. Mol Ther Nucleic Acids. 2021. PMID: 34976433 Free PMC article.

7

Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.

Yang S, Ni H, Zhang A, Zhang J, Liang H, Li X, Qian J, Zang H, Ming Z. Yang S, et al. J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w. J Cancer Res Clin Oncol. 2024. PMID: 39367929 Free PMC article.

8

H19 Rises in Gastric Cancer and Exerts a Tumor-Promoting Function via miR-138/E2F2 Axis.

Yu J, Fang C, Zhang Z, Zhang G, Shi L, Qian J, Xiong J. Yu J, et al. Cancer Manag Res. 2020 Dec 21;12:13033-13042. doi: 10.2147/CMAR.S267357. eCollection 2020. Cancer Manag Res. 2020. PMID: 33376397 Free PMC article.

9

Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues.

Yang S, Liang H, Li X, Qian J, Ming Z. Yang S, et al. Hepatol Int. 2024 Aug;18(4):1336-1337. doi: 10.1007/s12072-024-10651-z. Epub 2024 Feb 8. Hepatol Int. 2024. PMID: 38329702 No abstract available.

10

Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed.

Yang S, Liang H, Li X, Qian J, Ming Z. Yang S, et al. Hepatol Int. 2024 Jun;18(3):1058-1059. doi: 10.1007/s12072-024-10676-4. Epub 2024 May 8. Hepatol Int. 2024. PMID: 38717694 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters